Key Highlights

• FMC Corporation (NYSE: FMC) will sell 30,319,166 shares to the investor at $13.30 per share, for an aggregate purchase price of $403,244,907.80.

• The investor’s stake will rise from less than 1% to approximately 20% of FMC’s outstanding common stock.

• The agreement grants board nomination rights and imposes a 36-month lock-up period on share transfers.

• Preemptive rights allow the investor to maintain its ownership percentage under specified conditions.

FMC Corporation (NYSE: FMC) has finalized a strategic equity agreement with a major investor, positioning the company to enhance its financial flexibility while expanding its shareholder base. The transaction reflects a broader trend in the agricultural and specialty chemicals sector, where companies often seek capital infusions to support growth initiatives, research and development, or strategic acquisitions.

Investment Terms

Under the agreement, FMC will issue 30,319,166 shares of its common stock, par value $0.10 per share, at a price of $13.30 per share. The sale will generate proceeds for the company while significantly increasing the investor’s ownership stake. Prior to the transaction, the investor held less than 1% of FMC’s outstanding shares, but following the deal, its ownership is expected to reach approximately 20%.

The closing of the transaction remains subject to regulatory approvals and other customary conditions.

Board Representation

The agreement includes provisions for board-level influence, contingent on the investor’s ownership percentage. If the investor maintains at least 10% of FMC’s outstanding shares, it will gain the right to nominate a director to the company’s board. Additionally, the investor will appoint an independent observer, ensuring ongoing engagement in corporate governance matters.

These rights will remain in effect as long as the investor’s stake meets or exceeds the 10% threshold.

Lock-Up and Transfer Restrictions

To ensure stability in FMC’s shareholder structure, the investor has agreed to a 36-month lock-up period, during which it will be prohibited from transferring or hedging its shares. Even after the lock-up expires, certain restrictions will remain in place, including limitations on transfers to competitors, activist investors, or any entity that would result in a stake exceeding 4.9%. These measures are designed to prevent disruptive changes in ownership during the early stages of the investor’s involvement.

Preemptive and Voting Rights

The agreement grants the investor preemptive rights, allowing it to participate in future equity offerings to maintain its ownership percentage under specified conditions. Additionally, the investor has committed to voting its shares in alignment with FMC’s board recommendations, except in scenarios involving a change of control. These provisions are intended to align the investor’s interests with those of the company while preserving FMC’s operational independence.

Registration and Confidentiality

FMC will provide the investor with demand registration rights, enabling it to register its shares for public resale up to eight times over the life of the agreement. The investor will also gain access to certain non-public information, subject to strict confidentiality obligations. These terms are structured to balance the investor’s need for liquidity with the company’s interest in protecting sensitive business data.

Regulatory and Closing Conditions

The transaction is being conducted under exemptions from registration requirements under the Securities Act of 1933, avoiding the need for a public offering. Regulatory approvals and other customary closing conditions must be satisfied before the deal can be finalized. FMC anticipates completing the transaction in the near term, pending these approvals.

 

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.